1. Sasidharan S, Saudagar P. Leishmaniasis: where are we and where are we heading? Parasitol Res. 2021;120(5):1541-54.
2. Saini I, Joshi J, Kaur S. Unwelcome prevalence of leishmaniasis with several other infectious diseases. Int. Immunopharmacol. 2022; 110:109059.
3. Abadías-Granado I, Diago A, Cerro PA, Palma-Ruiz AM, Gilaberte YJ. Cutaneous and mucocutaneous leishmaniasis. Actas Dermosifiliogr (Engl Ed). 2021; S0001-7310(21)00108-3.
4. World Health Organization. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva. 2010; 22-26.
5. de Vries HJ, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022 ;23(6):823-40.
6. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017; 6:750.
7. Moya-Salazar J, Pasco IA, Cañari B, Contreras-Pulache H. Cutaneous leishmaniasis associated with the level of poverty of the Andean rural population: A five-year single-center study. Electron J Gen Med. 2021; 18 (6): em335.
8. Ujiie H, Rosmarin D, Schön MP, Ständer S, Boch K, Metz M, Maurer M, Thaci D, Schmidt E, Cole C, Amber KT. Unmet medical needs in chronic, non-communicable inflammatory skin diseases. Front Med (Lausanne). 2022; 9:875492.
9. Abdul-Hussein A, Yousif A, Abed O, Jabbar A. Cutaneous leishmaniasis: A clinicoepidemiological study in Al-Muthanna Governorate, Iraq. Al- Anbar Med J. 2023; 19(1): 30−35.
10. Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the middle East: prevalence and epidemiology. PLoS Negl Trop Dis. 2014; 8(10):e3208.
11. Rahi AA, Hashim ZK, Al-Jamea AM. Epidemiological Study of Cutaneous Leishmaniasis in Wasit Province. Indian J Forensic Med Toxicol. 2021; 15(4):526-529.
12. Singh V, Kumar A, editors. Visceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis: Pathogenesis, Treatment and Disease Control. 1st Ed. CRC Press; 2025.
13. Farooq I, Singh R, Selvapandiyan A, Ganguly NK. The Burden of Visceral Leishmaniasis: Need of Review, Innovations, and Solutions. In Challenges and Solutions Against Visceral Leishmaniasis. Singapore: Springer Nature Singapore. 2023. 28 (pp. 1-17).
14. Deb RM. Hurdles to achieving effective vector control for visceral leishmaniasis elimination in India. [PhD dissertation]. The University of Liverpool (United Kingdom); 2022.
15. Abid BK. Epidemiological study of the Kala azar cases in Iraq for years 1999-2003 . Iraqi J Vet Med. 2004; 28(1):168-180.
16. Ali MA, Khamesipour A, Rahi AA, Mohebali M, Akhavan AA. Epidemiological study of cutaneous leishmaniasis in some Iraqi provinces. Journal of Men's Health. 2018; 14(4):18-24.
17. AlSamarai AM, AlObaidi HS. Cutaneous leishmaniasis in Iraq. J Infect Dev Ctries. 2009; 3:123–129.
18. Alaa NH. Epidemiology of skin diseases in Tikrit and vicinity: a community based study. [MSc thesis] Tikrit University College of Medicine. 2002.
19. Murtada SJ. Epidemiology of skin diseases in Kirkuk. [MSc thesis], Tikrit University College of Medicine. 2001.
20. Alsamarai AGM. Prevalence of Skin Diseases in Samara, Iraq. Int J Dermatol. 2009; 48(7):734-9.
21. Faulde M, Schrader J, Heyl G, Amirih M. Differences in transmission seasons as an epidemiological tool for characterization of anthroponotic and zoonotic cutaneous leishmaniasis in northern Afghanistan. Acta Trop. 2008; 105:131-138.
22. Jorquera A, Ledezma E, Sousa L, et al. Epidemiologic characterization of American cutaneous leishmaniasis in an endemic region of Eastern Veezula. Am J Trop Med Hyg 1998; 58:589-593.
23. Akcali C, Culha G, Inaloz HS, Savaş N, Önlen Y, Savaş L, Kırtak N. Cutaneous leishmaniasis in Hatay. J Turk Acad Dermatol. 2007; 1:1.
24. Al-Cindan Y, Abdul-Aziz O, Kubba R. Cutaneous leishmaniasis in Al-Hassa, Saudi Arabia. Int J Dermatol. 1984; 23 (3):194–197.
25. Al-Taqi M, and Behbehani K. Cutaneous leishmaniasis in Kuwait. Ann Trop Med Parasitol. 1980; 74(5): 495–501.
26. Al-Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956–2002). Int J Infect Dis. 2004; 8(4): 244–250.
27. Al-Sabawi BH, Al-kallak SN, Al-Niaeemi BH. Cutaneous Leishmanasis and Health Awareness to Prevent its Spread in Nineveh Governorate, Iraq. Ann Rom Soc Cell Biol. 2021;25(4):10937-48.
28. Al-Naimy AF, Al-Waaly AB. Investigation of Cutaneous Leishmaniasis Cases in Baghdad province, Iraq. Medico Legal Update. 2021; 21(1):65-9.
29. Sanei-Dehkordi A, Soleimani-Ahmadi M, Zare M, Mirzaei H. Epidemiological features of cutaneous leishmaniasis and distribution of sand flies in an endemic area in southeast of Iran. Parasite Epidemiol Control. 2021; 14:e00220.
30. Talari SA, Shajari G, Talaei RClinical finding of cutaneous leishmaniasis as a new focus of Iran. Internet J Infect Dis. 2005; 5 (2):1-5.
31. Al Zadawi KA, Al-Nori TA, Ali BM, Al-Diwand JK. Knowledge about Cutaneous Leishmaniasis among the population in Baghdad Iraq, 2021. Iraqi New Medical Journal. 2024; 10(20): 82-88.
32. Wesołowska A. Sex—the most underappreciated variable in research: insights from helminth-infected hosts. Vet Res. 2022; 53(1):94.
33. Sellau J, Hansen CS, Gálvez RI, et al. Immunological clues to sex differences in parasitic diseases. Trends Parasitol. 2024; 40(11):1029-1041.
34. Bailey MS and Diana NJ. Cutaneous leishmaniasis. Clin Dermatol. 2007; 25: 203-211.
35. Fellah H, Rhajoui M, Ouahabi S, Belghiti D and Lyagoubi M.Occurrence of Human Cutaneous Leishmaniasis in Zouagha My Yacoub Province (Morocco). Int J Agri Biol. 2007; 9 (1):197-198.
36. Alzahrani MJ, Elfaki N, Abdalla YHA, et al. Cutaneous leishmaniasis: Associated risk factors and prevention in Hubuna, Najran, Saudi Arabia. Int J Gen Med. 2023; 16: 723–731.
37. Pearson R, and S. De Queiroz, “Leishmania Species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis,” in Principles and Practice of Infectious Diseases, G. Mandell, J. Bennett, and R. Dolin, Eds., 4th ed.New York, NY: Churchill Livingstone, 1995, P. 2434.
38. Ramirez JR, Agudelo S, Muskus C, et al. Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol. 2000; 38:3768-3773.
39. Courtenay O, Peters NC, Rogers ME, Bern C. Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control. PLoS Pathog. 2017; 13(10):e1006571.
40. Githeko AK, Lindsay SW, Confalonieri UE, Patz JA. Climate change and vector-borne diseases: A regional analysis. Bull World Health Organ. 2000; 78(9):1136-47.
41. Darkaoui N, Idrisi AJ, Talbi FZ, et al. Seasonal dynamics of sand flies (Diptera, Pshycodidae), vectors of cutaneous leishmaniasis, in the City of Fez, Northern Morocco. ScientificWorldJournal. 2022; 2022:4095129.
42. Asadi A, Moradinazar M, Marzbani B, et al. Epidemiological Study of Cutaneous Leishmaniasis in Kermanshah Province, 2011-2019. J Mazandaran Univ Med Sci. 2022; 32 (212): 155-162.